Trials / Unknown
UnknownNCT05672498
Effect of a Traditional Chinese Medicine Formulation on COVID-19 Infection
A Comparative Study on the Therapeutic Effect of a Traditional Chinese Medicine Formulation on COVID-19 Infection
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- First Affiliated Hospital Xi'an Jiaotong University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Traditional Chinese medicine (TCM) has been handed down for thousands of years. It has a long history in the treatment of virus infection and has a good effect on the upper respiratory tract infection. In recent years, the project applicant has been conducting research on the anti infection and anti inflammation treatment of traditional Chinese medicine, and has carried out a lot of clinical practice exploration in non-specific inflammation. The purpose of this research is to study the therapeutic effect of a traditional Chinese medicine prescription on COVID-19 infection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Traditional Chinese Medicine Formulation | The TCM Treatment Group:The patient are given a traditional Chinese medicine formulation, taking 150 ml of liquid medicine every morning and evening for 7 days. |
| OTHER | Placebo Treatment | Placebo Treatment Group:The patient are given placebo, taking 150 ml of liquid placebo every morning and evening for 7 days. All medications and placebo are packed identically in packing bags with the same labeling form. |
Timeline
- Start date
- 2023-01-05
- Primary completion
- 2023-04-05
- Completion
- 2023-05-05
- First posted
- 2023-01-05
- Last updated
- 2023-01-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05672498. Inclusion in this directory is not an endorsement.